Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Randy L. Fast"'
Autor:
Jennifer L. Dankmeyer, Randy L. Fast, Christopher K. Cote, Patricia L. Worsham, David Fritz, Diana Fisher, Steven J. Kern, Tod Merkel, Carsten J. Kirschning, Kei Amemiya
Publikováno v:
Journal of Immunology Research, Vol 2014 (2014)
The current candidate vaccine against Yersinia pestis infection consists of two subunit proteins: the capsule protein or F1 protein and the low calcium response V protein or V-antigen. Little is known of the recognition of the vaccine by the host’s
Externí odkaz:
https://doaj.org/article/29c421df1ac74c64a397af27252545f7
Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model.
Autor:
Xiaodong Xiao, Zhongyu Zhu, Jennifer L Dankmeyer, Michael M Wormald, Randy L Fast, Patricia L Worsham, Christopher K Cote, Kei Amemiya, Dimiter S Dimitrov
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13047 (2010)
Yersinia pestis is the etiologic agent of plague that has killed more than 200 million people throughout the recorded history of mankind. Antibiotics may provide little immediate relief to patients who have a high bacteremia or to patients infected w
Externí odkaz:
https://doaj.org/article/0ada85b2aa504f6398d78d2124b31774
Autor:
Sarah L. Norris, Anthony D. Bassett, Bradford S. Powell, Patricia L. Worsham, Randy L. Fast, Jeffrey J. Adamovicz, Arthur M. Krieg, Kei Amemiya, Jennifer L. Meyers, Taralyn E. Rogers
Publikováno v:
Vaccine. 27:2220-2229
The current U.S. Department of Defense candidate plague vaccine is a fusion between two Yersinia pestis proteins: the F1 capsular protein, and the low calcium response (Lcr) V-protein. We hypothesized that an immunomodulator, such as CpG oligodeoxynu
Autor:
Tod J. Merkel, David Fritz, Patricia L. Worsham, Christopher K. Cote, Jennifer L. Dankmeyer, Randy L. Fast, Diana Fisher, Kei Amemiya, Steven J. Kern, Carsten J. Kirschning
Publikováno v:
Journal of Immunology Research
Journal of Immunology Research, Vol 2014 (2014)
Journal of Immunology Research, Vol 2014 (2014)
The current candidate vaccine againstYersinia pestisinfection consists of two subunit proteins: the capsule protein or F1 protein and the low calcium response V protein or V-antigen. Little is known of the recognition of the vaccine by the host’s i
Autor:
Jeffrey J. Adamovicz, Randy L. Fast, Nicolas A. Parejo, Martina Kinzig-Schippers, Steven M. Opal, Fritz Sörgel, Arnold Louie, Lynda Miller, George L. Drusano, Kei Amemiya, John E. Palardy, Henry S. Heine
It has been previously shown that mice subjected to an aerosol exposure to Yersinia pestis and treated with β-lactam antibiotics after a delay of 42 h died at an accelerated rate compared to controls. It was hypothesized that endotoxin release in an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e08aabaf7b03ddb2e5c0eb5c22bf434
https://www.ncbi.nlm.nih.gov/pubmed/24687492
https://www.ncbi.nlm.nih.gov/pubmed/24687492
Autor:
Dimiter S. Dimitrov, Kei Amemiya, Patricia L. Worsham, Randy L. Fast, Christopher K. Cote, Jennifer L. Dankmeyer, Zhongyu Zhu, Xiaodong Xiao, Michael M. Wormald
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13047 (2010)
PLoS ONE
PLoS ONE
Yersinia pestis is the etiologic agent of plague that has killed more than 200 million people throughout the recorded history of mankind. Antibiotics may provide little immediate relief to patients who have a high bacteremia or to patients infected w